Successful treatment with guanfacine in a long-COVID case manifesting marked cognitive impairment.
Tsuyoshi KondoRiki HigaMariko KunibaHotaka ShinzatoYoshikazu TakaesuPublished in: Neuropsychopharmacology reports (2024)
GXR may be helpful in improving subjective/objective cognitive functioning and frontotemporal brain activity in long-COVID patients manifesting apparent cognitive impairment.